Sugi Predict

Sugi Predict / Compounds / SCHEMBL468538

SCHEMBL468538

SCHEMBL468538

c1ccc(C2OC[C@@H]3OC(c4ccccc4)O[C@H]([C@H]4COC(c5ccccc5)O4)[C@@H]3O2)cc1

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.57
▸ MEN1 O00255 3/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ MAPT P10636 3/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ CYP2C19 P33261 1/20 0.42
▸ LMNA P02545 2/20 0.38
▸ ATM Q13315 2/20 0.38
▸ MITF O75030 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ADRA1A P35348 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20747758 1.00 KMT2A (0.57) KMT2AMEN1L3MBTL1MAPTCYP3A4
SCHEMBL2692621 0.91 KMT2A (0.56) KMT2AMEN1L3MBTL1MAPTCYP3A4
SCHEMBL19976423 0.91 KMT2A (0.56) KMT2AMEN1L3MBTL1MAPTCYP3A4
SCHEMBL769362 0.91 KMT2A (0.56) KMT2AMEN1L3MBTL1MAPTCYP3A4
SCHEMBL10075962 0.91 KMT2A (0.56) KMT2AMEN1L3MBTL1MAPTCYP3A4
SCHEMBL200621 0.91 KMT2A (0.56) KMT2AMEN1L3MBTL1MAPTCYP3A4
SCHEMBL3486991 0.91 KMT2A (0.56) KMT2AMEN1L3MBTL1MAPTCYP3A4
SCHEMBL12754596 0.91 KMT2A (0.56) KMT2AMEN1L3MBTL1MAPTCYP3A4
SCHEMBL7152479 0.90 KMT2A (0.52) KMT2AMEN1L3MBTL1MAPTCYP3A4
SCHEMBL29306388 0.90 KMT2A (0.52) KMT2AMEN1L3MBTL1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8231884-B2 Polymer or surfactant enveloping oriented fibers; mass formed by 3:2,4-di-O-benzylidene-D-sorbitol organogelator; oblong particles have beneficial iridescent properties; soft-focus effect properties; make-up and foundation improve visual appearance of skin PIERRE FABRE DERMO-COSMETIQUE (FR) 2012-07-31 — — US claimed
US-20080248071-A1 Diffusing Particles Based on Organogelling Xerogel Fibers, Method for Preparing Same and Use in Cosmetic Formulations PIERRE FABRE DERMO-COSMETIQUE (FR) 2008-10-09 — — US claimed
EP-1928403-A1 DIFFUSING PARTICLES BASED ON ORGANOGELLING XEROGEL FIBERS, METHOD FOR PREPARING SAME AND USE IN COSMETIC FORMULATIONS Pierre Fabre Dermo-Cosmetique (FR) 2008-06-11 — — EP claimed
WO-2007039561-A1 DIFFUSING PARTICLES BASED ON ORGANOGELLING XEROGEL FIBERS, METHOD FOR PREPARING SAME AND USE IN COSMETIC FORMULATIONS PIERRE FABRE DERMO-COSMETIQUE (FR) 2007-04-12 — — WO claimed
US-11697735-B2 Solid oleaginous compositions TOTAL MARKETING SERVICES (FR) 2023-07-11 — — US disclosed
US-11365317-B2 Solid binders TOTAL MARKETING SERVICES (FR) 2022-06-21 — — US disclosed
EP-3612616-B1 SOLID BITUMEN AT AMBIENT TEMPERATURE TOTAL MARKETING SERVICES (FR) 2022-06-01 — — EP disclosed
US-11332606-B2 Clear binder that is solid when cold TOTAL MARKETING SERVICES (FR) 2022-05-17 — — US disclosed
CN-110050035-B Solid oleaginous compositions 道达尔销售服务公司 2022-05-13 — — CN disclosed
US-20220145079-A1 BITUMINOUS COMPOSITION SOLID AT AMBIENT TEMPERATURE TOTAL MARKETING SERVICES (FR) 2022-05-12 — — US disclosed
EP-3510103-B1 CLEAR SOLID COLD BINDER TOTAL MARKETING SERVICES (FR) 2022-02-16 — — EP disclosed
US-11242287-B2 Bitumen which is solid at ambient temperature TOTAL MARKETING SERVICES (FR) 2022-02-08 — — US disclosed
US-20080248071-A1 Diffusing Particles Based on Organogelling Xerogel Fibers, Method for Preparing Same and Use in Cosmetic Formulations PIERRE FABRE DERMO-COSMETIQUE (FR) 2008-10-09 — — US disclosed
WO-2008107551-A2 BITUMINOUS COMPOSITION WITH THERMOREVERSIBLE PROPERTIES TOTAL RAFFINAGE MARKETING (FR) 2008-09-12 — — WO disclosed
EP-1928403-A1 DIFFUSING PARTICLES BASED ON ORGANOGELLING XEROGEL FIBERS, METHOD FOR PREPARING SAME AND USE IN COSMETIC FORMULATIONS Pierre Fabre Dermo-Cosmetique (FR) 2008-06-11 — — EP disclosed
WO-2007039561-A1 DIFFUSING PARTICLES BASED ON ORGANOGELLING XEROGEL FIBERS, METHOD FOR PREPARING SAME AND USE IN COSMETIC FORMULATIONS PIERRE FABRE DERMO-COSMETIQUE (FR) 2007-04-12 — — WO disclosed
US-6562514-B1 Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries PINNACLE VRB LIMITED (AU) 2003-05-13 — — US disclosed
US-6468688-B2 CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE PINNACLE VRB LIMITED (AU) 2002-10-22 — — US disclosed
US-20010028977-A1 Charging, discharging efficiency; vanadium electrolyte JD HOLDING INC. (KY) 2001-10-11 — — US disclosed
US-6143443-A ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE PINNACLE ARB LIMITED (AU) 2000-11-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080248071-A1 Diffusing Particles Based on Organogelling Xerogel Fibers, Method for Preparing Same and Use in Cosmetic Formulations SORD, DPM1, SUCLG1 KMT2A 4519/4885MEN1 2518/4885L3MBTL1 4807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.